Article
Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung Adenocarcinoma.
Clinical lung cancer - 1 Nov 2018
Oezkan Filiz, Herold Thomas, Darwiche Kaid, Eberhardt Wilfried E E, Worm Karl, Christoph Daniel C, Wiesweg Marcel, Freitag Lutz, Schmid Kurt-Werner, Theegarten Dirk, Hager Thomas, Koenig Michael J, He Kai, Taube Christian, Schuler Martin, Breitenbuecher Frank
Abstract excerpt
BACKGROUND: First-line afatinib treatment prolongs overall survival in patients with metastatic non-small-cell lung cancer (NSCLC) harboring exon 19 deletion of epidermal growth factor receptor (EGFRdelEx19) mutations. In contrast, Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) mutations are negative predictors for benefit from EGFR-targeting agents. Endobronchial ultrasound-guided transbronchial needle...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
